| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |